Nutrients and the surgical patient: Current and potential therapeutic applications to clinical practice

Journal of the Royal College of Surgeons of Edinburgh

Volumn 44, Issue 5, 1999, Pages 283-293

  Heys, Steven D ^a,b   Gardner, Earl ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Nutrients; Nutritional pharmacology; Nutritional support

Indexed keywords

CELL; CELL FUNCTION; CLINICAL PRACTICE; HUMAN; IMMUNE SYSTEM; MAJOR CLINICAL STUDY; MALNUTRITION; METABOLISM; MORBIDITY; MORTALITY; NUTRITIONAL SUPPORT; ORGAN; OUTCOMES RESEARCH; POSTOPERATIVE PERIOD; REVIEW; SURGICAL PATIENT; WEIGHT REDUCTION; WOUND HEALING;

HUMANS; IMMUNE SYSTEM; NUTRITION DISORDERS; NUTRITIONAL STATUS; NUTRITIONAL SUPPORT; POSTOPERATIVE COMPLICATIONS; SURGICAL PROCEDURES, OPERATIVE; WEIGHT LOSS; WOUND HEALING;

EID: 0032847605     PISSN: 00358835     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (110)

1. McWhirter JP, Pennington CR. Incidence and recognition of malnutrition in hospital. BMJ 1994; 308(6934):945-8
2. Detsky AS, Baker JP, O'Rourke K, Johnston N, Whitewell J, Mendelson RA, Jeejeebhoy KN. Predicting nutrition-associated complications for patients undergoing gastrointestinal surgery. JPEN J Parenter Enteral Nutr 1987; 11(5):440-6
3. Hill GL. In: ed Hill GL, Disorders of Nutrition and Metabolism in Clinical Surgery. Edinburgh:Churchill Livingstone, 1992
4. Meguid MM, Campos AA, Hammond WG. Nutritional support in surgical practice: Part I. Am J Surg 1990; 159(3): 345-58. Review
5. Heys SD, Gough DB, Khan L, Eremin O. Nutritional pharmacology and malignant disease: a therapeutic modality in patients with cancer. Br J Surg 1996; 83(5): 608-19. Review
6. Heys SD, Khan AL, Eremin O. Immunosuppression in surgery. Postgrad Surg 1995; 5: 62-67.
7. Kirk SJ, Barbul A. Role of arginine in sepsis, trauma and immunity. JPEN J Parenter Enteral Nutr 1990; 14(5 Suppl):226S-229S
8. Rose WC. The amino acid requirements of adult man. Nutr Abs Rev 1957; 27: 631-647.
9. Visek WJ. Arginine needs physiological state and usual diets. A reevaluation. J Nutr 1986; 116(1):36-46
10. Walser M. Urea cycle disorders and other hereditary disorders in hyperammonemic syndromes. In: Stanbury JB, Wyngaarden JB, Fredrickson DS, Goldstein JL, Brown MS, eds. The metabolic basis of inherited disease. New York: McGraw-Hill, 1978: 402-438
11. Moncada S, Palmer RM, Higgs A. Biosynthesis of nitric oxide from L-arginine. Biochem Pharmacol 1989 Jun 1;38(11):1709-15
12. Marietta MA, Tayeh MA, Hevel JM. Unravelling the significance of nitric oxide. Biofactors 1990; 2(4): 219-25
13. Reynolds JV, Daly JM, Shou J, Sigal R, Ziegler MM, Naji A. Immunologic effects of arginine supplementation in tumor-bearing and non-tumor-bearing hosts. Ann Surg 1990; 211(2): 202-10
14. Barbul A, Wasserkrug HL, Sisto DA, Seifter E, Rettura G, Levenson SM, Efron G. Thymic stimulatory actions of arginine. JPEN J Parenter Enteral Nutr 1980; 4(5):446-9
15. Nirgiotis JG, Hennessey PJ, Andrassy RJ. The effects of an arginine-free enteral diet on wound healing and immune function in the postsurgical rat. J Pediatr Surg 1991; 26(8): 936-41
16. Daly JM, Reynolds J, Thom A, Kinsley L, Dietrick-Gallagher M, Shou J, Ruggieri B. Immune and metabolic effects of arginine in the surgical patient. Ann Surg 1988; 208(4): 512-23
17. Barbul A, Sisto DA, Wasserkrug HL, Efron G. Arginine stimulates lymphocyte immune response in healthy human beings. Surgery 198; 90(2): 244-51
18. Park KG, Hayes PD, Garlick PJ, Sewell H, Eremin O. Stimulation of lymphocyte natural cytotoxicity by L-arginine. Lancet 1991; 337(8742): 645-6
19. Brittenden J, Park KG, Heys SD, Ross C, Ashby J, Ah-See AK, Eremin O. L-Arginine stimulates host defenses in patients with breast cancer. Surgery 1994; 115(2): 205-12
20. Brittenden J, Heys SD, Ross J, Park KGM, Eremin O. Natural cytotoxicity in breast cancer patients receiving neoadjuvant chemotherapy: effects of L-arginine supplementation. Eur J Surg Oncol 1994; 20(4): 467-72
21. Heys SD, Segar A, Payne S, Bruce DM, Kernohan N, Eremin O. Dietary supplementation with L-arginine: modulation of tumour-infiltrating lymphocytes in patients with colorectal cancer. Br J Surg 1997; 84(2): 238-41
22. Brittenden J, Heys SD, Ross J, Park KGM, Eremin O. Nutritional pharmacology: effects of L-arginine on host defences, response to trauma and tumour growth. Clin Sci (Colch) 1994; 86(2): 123-32
23. Bergstrom J, Furst P, Noree LO, Vinnars E. Intracellular free amino acid concentration in human muscle tissue. J Appl Physiol 1974; 36(6): 693-7
24. Vinnars E, Bergstrom J, Furst P. Influence of the postoperative state on the intracellular free amino acids in human muscle tissue. Ann Surg 1975; 182(6):665-71
25. Roth E, Furnovics J, Muhlbacher F et al. Metabolic disorders in severe abdominal sepsis: glutamine deficiency in skeletal muscle. Clin Nutr 1982; 1: 25-41
26. O'Riordain MG, Fearon KC, Ross JA, Rogers P, Falconer JS, Bartolo DC, Garden OJ, Carter DC. Glutamine-supplemented total parenteral nutrition enhances T-lymphocyte response in surgical patients undergoing colorectal resection. Ann Surg 1994; 220(2):212-21
27. Khan AL, Heys SD, Eremin O. Synthetic polyribonucleotides: current role and potential use in oncological practice.Eur J Surg Oncol 1995; 21(2):224-7
28. Wiltrout RH, Salup RR, Twillwy TA, Talmadge JE. Immunomodulation of natural killer activity by polyribonudeotides.J Biol Response Mod 1985; 4(5): 512-7
29. Adjei AA, Takamine F, Yokoyama H, Shiokawa K, Matsumoto Y, Asato L, Shinjo S, Imamura T, Yamamoto S. The effects of oral RNA and intra-peritoneal nucleoside-nucleotide administration on methicillin-resistant staphylococcus aureus infection in mice. JPEN J Parenter Enteral Nutr 1993; 17(2): 148-52
30. Hovanessian AG, Youn JK, Buffet-Janvresse C, Riviere Y, Michelson M, Lacour J, Lacour F. Enhancement of natural killer cell activity and 2-5A synthetase in operable breast cancer patients treated with polyadenylic; polyuridylic acid. Cancer 1985; 55(2):357-62
31. Youn JK, Kim BS, Min JS, Lee KS, Choi HJ, Lee YB, Lee DW, Koh EH, Kim KW, Lee KB, et al. Adjuvant treatment of operable stomach cancer with polyadenylic.polyuridylic acid in addition to chemotherapeutic agents. Differential effect on natural killer cell and antibody-dependent cellular cytotoxicity. Int J Immunopharmacol 1987; 9(3): 313-24
32. Khan AL, Richardson S, Drew J, Larsen F, Campbell M, Heys SD, Ah-See AK, Eremin O. Polyadenylic-polyuridylic acid enhances the natural cell-mediated cytotoxicity in patients with breast cancer undergoing mastectomy. Surgery 1995; 118(3):531-8
33. Braun W, Ishizuka M, Yajima Y et al. Spectrum and mode of actions of poly A:U in the stimulation of immune responses. In: Beers RF, Braun W (Eds). Biological effect of polyribonucleotides. New York: Springer, 1971: 139
34. Horrobin DF, Manku MS. Clinical biochemistry of essential fatty acids. In: Horrobin DF, Ed. Omega-6 essential fatty acids: Pathophysiology and roles in clinical medicine. New York: Alan R Liss, 1990: 21-53
35. Manner T, Katz DP, Skeie B, Newsholme E, Kirvela O, Askanazi J. Fish oils and the lung. Clin Nutr 1993; 12: 131-46
36. Mitsuhashi N, Takano A, Kato J. Inhibition of the binding of R-5020 and rat uterine progesterone receptors by long chain fatty acids. Endocrinol Jpn 1986; 33(2): 251-6
37. Cave WT Jr, Erickson-Lucas MJ. Effects of dietary lipids on lactogenic hormone receptor binding in rat mammary tumors. J Natl Cancer Inst 1982; 68(2):319-24
38. Alexander JW, Saito H, Trocki O, Ogle CK. The importance of lipid type in the diet after burn injury. Ann Surg 1986; 204(1):1-8
39. Billiar TR, Bankey PE, Svingen BA, Curran RD, West MA, Holman RT, Simmons RL, Cerra FB. Fatty acid intake and Kupffer cell function: fish oil alters eicosanoid and monokine production to endotoxin stimulation. Surgery 1988; 104(2): 343-9
40. Purasiri P, Ashby J, Heys SD, Eremin O. Effect of essential fatty acids on circulating T cell subsets in patients with colorectal cancer. Cancer Immunol Immunother 1994; 39(4) 217-22
41. Purasiri P, Ashby J, Heys SD, Eremin O. Effect of essential fatty acids on natural cytotoxicity in patients with colorectal cancer. Eur J Surg Oncol 1995; 21(3):254-60
42. Purasiri P, Murray A, Richardson S, Heys SD, Horrobin D, Eremin O. Modulation of cytokine production in vivo by dietary essential fatty acids in patients with colorectal cancer. Cli Sci 1994; 87: 711-17
43. Purasiri P, McKechnie A, Heys SD, Eremin O. Modulation in vitro of human natural cytotoxicity, lymphocyte proliferative response to mitogens and cytokine production by essential fatty acids. Immunology 1997; 92(2): 166-72
44. Barber MD, Ross JA, Preston T, Shenkin A, Fearon KC. Fish oil-enriched nutritional supplement attenuates progression of the acute-phase response in weight-losing patients with advanced pancreatic cancer. J Nutr 1999; 129(6):1120-5
45. Elsair J, Poey J, Isaad J et al. Effect of arginine chlorhydrate on nitrogen balance during the three days following surgery in man. Biomedicine 1978; 29: 312-7
46. Daly JM, Reynolds J, Thom A, Kinsley L, Dietrick-Gallagher M, Shou J, Ruggieri B. Immune and metabolic effects of arginine in the surgical patient. Ann Surg 1988; 208(4):512-23
47. Barbul A, Rettura G, Levenson SM, Seifter E. Wound healing and thymotropic effects of arginine: a pituitary mechanism of action. Am J Clin Nutr 1983; 37(5):786-94
48. Barbul A, Lazarou SA, Efron DT, Wasserkrug HL, Efron G. Arginine enhances wound healing and lymphocyte immune responses in humans. Surgery 1990; 108(2): 331-337
49. Wernerman J, Hammarqvist F, von der Decken A, Vinnars E. Ornithine-alpha-ketoglutarate improves skeletal muscle protein synthesis as assessed by ribosome analysis and nitrogen balance used after surgery. Ann Surg 1987; 206(5):674-8
50. Hammarqvist F, Wernerman J, Ali R, von der Decken A, Vinnars E. Addition of glutamine to total parenteral nutrition after elective abdominal surgery spares free glutamine in muscle, counteracts the fall in muscle protein synthesis, and improves nitrogen balance. Ann Surg 1989; 209(4):455-61
51. Stehle P, Zander J, Mertes N, Albers S, Puchstein C, Lawin P, Furst P .Effect of parenteral glutamine peptide supplements on muscle glutamine loss and nitrogen balance after major surgery. Lancer 1989;1(8632):231-3
52. Ziegler TR, Young LS, Benfell K, Scheltinga M, Hortos K, Bye R, Morrow FD, Jacobs DO, Smith RJ, Antin JH, et al. Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation. A randomized, double-blind, controlled study. Ann Intern Med 1992; 116(10):821-8 .
53. Schloerb PR, Amare M. Total parenteral nutrition with glutamine in bone marrow transplantation and other clinical applications (a randomized, double-blind study). JPEN J Parenter Enteral Nutr 1993;17(5):407-13
54. Morlion BJ, Stehle P, Wachtler P, Siedhoff HP, Koller M, Konig W, Furst P, Puchstein C. Total parenteral nutrition with glutamine dipeptide after major abdominal surgery: a randomized, double-blind, controlled study. Ann Surg 1998; 227(2):302-8
55. Heys SD, Ashkanani F, Glutamine.Br J Surg 1999; 86(3): 289-90
56. Houdijk AP, Rijnsburger ER, Jansen J, Wesdorp RI, Weiss JK, McCamish MA, Teerlink T, Meuwissen SG, Haarman HJ, Thijs LG, van Leeuwen PA. Randomised trial of glutamine-enriched enteral nutrition on infectious morbidity in patients with multiple trauma. Lancet 1998; 352(9130): 772-6
57. Griffiths R, Jones C, Palmer TE. Six-month outcome of critically ill patients given glutamine supplemented nutrition. Nutrition 1997; 13(4): 295-302.
58. Byrne TA, Persinger RL, Young LS, Ziegler TR, Wilmore DW. A new treatment for patients with short-bowel syndrome. Ann Surg 1995; 222(3): 243-255.
59. Scolapio JS, Camilleri M, Fleming CR, Oenning LV, Burton DD, Sebo TJ, Batts KP, Kelly DG. Effect of growth hormone, glutamine, and diet on adaptation in short-bowel syndrome: a randomized, controlled study. Gastroenterology 1997; 113(4): 1074-81
60. Anderson PM, Schroeder G, Skubitz KM. Oral glutamine reduces the duration and severity of stomatitis after cytotoxic cancer chemotherapy. Cancer 1998; 83(7): 1433-1439.
61. Zorgniotti AW, Lizza EF. Effect of large doses of the nitric oxide precursor L-arginine on erectile dysfunction. Int J Impotence Res 1994; 6(1): 33-35.
62. Agostoni A, Marasini B, Biondi ML, Bassani C, Cazzaniga A, Bottasso B, Cugno M. L-arginine therapy in Raynaud's phenomenon? Int J Clin Lab Res 1991; 21(2):202-3
63. Loukides S, Kharitonov S, Wodehouse T, Cole PJ, Barnes PJ. Effect of arginine on mucociliary function in primary ciliary dyskinesia. Lancet 1998; 352(9125): 371-2
64. Park KG, Heys SD, Blessing K, Kelly P, McNurlan MA, Eremin O, Garlick PJ. Stimulation of human breast cancers by dietary L-arginine. Clin Sci (Colch) 1992; 82(4):413-7
65. Remvikos Y, Beuzeboc P, Zajdela A, Voillemot N, Magdelenat H, Pouillart P. Correlation of pretreatment proliferative activity of breast cancer with the response to cytotoxic chemotherapy. J Natl Cancer Inst 1989; 81(18): 1383-7
66. Heys SD, Ogston K, Miller I et al. Potentiation of the response to chemotherapy in patients with breast cancer by dietary supplementation with L-arginine: results of a randomised controlled trial. Int J Oncol 1998; 12(1): 221-5
67. Hawthorne AB, Daneshmend TK, Hawkey CJ, Belluzzi A, Everitt SJ, Holmes GK, Malkinson C, Shaheen MZ, Willars JE. Treatment of ulcerative colitis with fish oil supplementation: a prospective 12 month randomised controlled trial. Gut 1992; 33(7): 922-8
68. Ikehata A, Hiwatashi N, Kinouchi Y, Yamazaki H, Kumagai Y, Ito K, Kayaba Y, Toyota T. Effect of intravenously infused eicosapentaenoic acid on the leucotriene generation in patients with active Crohn's disease. Am J Clin Nutr 1992; 56(5): 938-42
69. Lorenz R, Weber PC, Szimnau P, Heldwein W, Strasser T, Loeschke K. Supplementation with n-3 fatty acids from fish oil in chronic inflammatory bowel disease: a randomized, placebo-controlled, double-blind cross-over trial. J Intern Med Suppl 1989; 225(731):225-32
70. Salomon P, Kornbluth AA, Janowitz HD. Treatment of ulcerative colitis with fish oil n-3 fatty acid: an open trial. J Clin Gastroenterol 1990;12(2):157-61
71. Almallah YZ, Richardson S, O'Hanrahan T, Mowat NA, Brunt PW, Sinclair TS, Ewen S, Heys SD, Eremin O. Distal procto-colitis, natural cytotoxicity, and essential fatty acids. Am J Gastroenterol 1998; 93(5):804-9
72. Gough DB, Heys SD, Eremin O. Cancer cachexia I. Pathogenesis. Eur J Surg Oncol 1996; 22(2): 192-6
73. Gough DB, Heys SD, Eremin O. Cancer cachexia II. Treatment strategies. Eur J Surg Oncol 1996; 22(2): 286-97
74. Wigmore SJ, Fearon KCH, Maingay JP, Ross JA. Down-regulation of the acute phase response in patients with pancreatic cancer receiving oral eicosapentaenoic acid is mediated via suppression of interleukin-6. Clin Sci (Colch). 1997; 92(2): 215-21
75. Dormandy TL. An approach to free radicals. Lancet 1983; 2(8357): 1010-4
76. Cornwell DG, Morisaki N. Fatty acid paradoxes in the control of cell proliferation: prostaglandins, lipid peroxides and cooxidation reactions. In: Pryor WA, Ed. Free radicals in biology. New York: Academic press, 1984, pp 95-148
77. Horrobin DF. Essential fatty acids, lipid peroxidation, and cancer. In: Horrobin DF, Ed. Omega-6 essential fatty acids: Pathophysiology and roles in clinical medicine. New York: Alan R Liss, 1990; 351-77
78. Begin ME, Ellis G, Horrobin DF. Polyunsaturated fatty acid induced cytotoxicity against tumor cells and its relationship to lipid peroxidation. J Natl Cancer Inst. 1988; 80(3): 188-94
79. Mengeaud V, Nano JL, Fournel S, Rampal P. Effects of eicosapentaenoic acid, gamma-Iinolenic acid and prostaglandin E1 on three human colon carcinoma cell lines. Prostaglandins Leukot Essent Fatty Acids 1992; 47(4):313-9
80. McMillan DN, Heys SD, Murray AW et al. Differential responses of human tumour cells to polyunsaturated fatty acids: stimulation of proliferation of a colon tumour cell line by docosahexaenoic acid. Int J Oncal 1995; 7: 923-7
81. Van der Merwe CF, Booyens J, Katzeff IE. Oral gamma-linolenic acid in 21 patients with untreatable malignancy. An ongoing pilot open trial. Br J Clin Pract 1987; 41(9): 907-15
82. Naidu MR, Das UN, Kishan A. Intratumoral gamma-linoleic acid therapy of human gliomas. Prostaglandins Leukot Essent Fatty Acids 1992; 45(3): 181-4
83. McIllmurray M, Turkie W. Controlled trial of gamma-linolenic acid in Dukes C colorectal cancer. Br Med J (Clin Res Ed) 1987; 294(6582): 1260
84. Germain E, Chajes V, Cognault S, Lhuillery C, Bougnoux P. Enhancement of doxorubicin cytotoxicity by polyun-saturated fatty acids in the human breast tumor cell line MDA-MB-231 : relationship to lipid peroxidation. Int J Cancer 1998; 75(4):578-83
85. Plumb JA, Luo W, Kerr DJ. Effect of polyunsaturated fatty acids on the drug sensitivity of human tumour cell lines resistant to either cisplatin or doxorubicin. Br J Cancer 1993; 67(4):728-33
86. Shao Y, Pardini L, Pardini RS. Intervention of transplantable human mammary carcinoma MX-1 chemotherapy with dietary menhaden oil in athymic mice: increased therapeutic effects and decreased toxicity of cyclophosphamide. Nutr Cancer 1997; 28(1):63-73
87. Bougnoux P, Germain E, Chajes V, Hubert B, Lhuillery C, Le Floch O, Body G, Calais G. Cytotoxic drugs efficacy correlates with adipose tissue docosahexaenoic acid level in locally advanced breast carcinoma. Br J Cancer 1999; 79(11-12): 1765-9
88. Horrobin DF, Manku MS. Clinical biochemistry of essential fatty acids: in: Horrobin DF. Ed. Omega-6 essential fatty acids; pathophysiology and roles in clinical medicine. New York: Wiley-Liss, 1990, pp 21-53.
89. Boyd NF, McGuire V, Shannon P, Cousins M, Kriukov V, Mahoney L, Fish E, Lickley L, Lockwood G, Tritchler D. Effect of a low fat high-carbohydrate diet on symptoms of cyclical mastopathy. Lancet 1988; 2(8603): 128-32
90. Mansel RE, Pye JK, Hughes LE. Effects of essential fatty acids on cyclical mastalgia and non-cyclical breast disorders, in: HoiTobin DF. Ed. Omega-6 essential fatty acids; pathophysiology and roles in clinical medicine. New York: Wiley-Liss, 1990, pp 557-566.
91. Gately CA, Pye JK, Harrison BJ et al. Evening primrose oil (Efamol), a safe treatment option for benign breast disease. Breast Cancer Res Treat 14:161.
92. Lacour J, Lacour F, Spira A, Michelson M, Petit JY, Delage G, Sarrazin D, Contesso G, Viguier J. Adjuvant treatment with polyadenylic-polyuridylic acid in operable breast cancer: updated results of a randomised trial. Br Med J (Clin Res Ed) 1984; 288(6417):589-92
93. Lacour J, Laplanche A, Delozier T, Berlie J, Mourali N, Julien JP, De Gislain C, Namer M, Petit JC, Denis V, et al. Polyadenylic-polyuridylic acid plus locoregional and pelvic radiotherapy versus chemotherapy with CMF as adjuvants in operable breast cancer. A 6 1/2 year followup analysis of a randomized trial of the French Federation of Cancer Centers (F.F.C.C.). Breast Cancer Res Treat 1991; 19(1):15-21
94. Youn JK, Kim BS, Min JS, Choi HJ, Lee YB, Lee DW, Koh EH, Kim KW, Lee KB, Michelson M. Adjuvant treatment with chemotherapeutic agents and polyadenylic-polyuridylic acid in operable stomach cancers. I. Enhancement of natural killer cell activity. Yonsei Med J 1985; 26(1): 1-7
95. Lacour J, Laplanche A, Malafosse M, Gallot D, Julien M, Rotman N, Guivarc'h M, Roullet-Audy JC, Lasser P, Hautefeuille P, et al. Polyadenylic-polyuridylic acid as an adjuvant in resectable colorectal carcinoma: a 6 1/2 year follow-up analysis of a multicentric double blind randomized trial. Eur J Surg Oncol 1992; 18(6): 599-604
96. Cerra FB, Lehman S, Konstantinides N, Konstantinides F, Shronts EP, Holman R. Effect of enteral nutrient on in vitro tests of immune function in ICU patients: a preliminary report. Nutrition 1990; 6(1): 84-87
97. Kemen M, Senkal M, Homann HH, Mumme A, Dauphin AK, Baier J, Windeler J, Neumann H, Zumtobel V. Early postoperative enteral nutrition with arginine-omega-3 fatty acids and ribonucleic acid-supplemented diet versus placebo in cancer patients: an immunologic evaluation of Impact. Crit Care Med 1995; 23(4):652-9
98. Daly JM, Lieberman MD, Goldfine J, Shou J, Weintraub F, Rosato EF. Enteral nutrition with supplemental arginine, RNA and omega-3 fatty acids after operation: immunologie, metabolic and clinical outcome. Surgery 1992; 112(1): 56-67.
99. Moore FA, Moore EE, Kudsk KA, Brown RO, Bower RH, Koruda MJ, Baker CC, Barbul A. Clinical benefits of an immune-enhancing diet for early postinjury enteral feeding. J Trauma 1994; 37(4):607-15
100. Bower RH, Cerra FB, Bershadsky B, Licari JJ, Hoyt DB, Jensen GL, Van Buren CT, Rothkopf MM, Daly JM, Adelsberg BR. Early enteral administration of a formula (Impact) supplemented with arginine, nucleotides, and fish oil in intensive care unit patients: results of a multicenter, prospective, randomized, clinical trial. Crit Care Med 1995; 23(3):436-49
101. Braga M, Vignali A, Gianotti L, Cestari A, Profili M, Di Carlo V. Benefits of early postoperative enteral feeding in cancer patients. Infusionsther Tramfusionsmed 1995; 22(5):280-4
102. Daly JM, Weintraub F, Shou J, Rosato EF, Lucia M. Enteral nutrition during multimodality therapy in upper gastrointestinal cancer patients. Ann Surg 1995; 221(4): 327-38
103. Kudsk KA, Minard G, Croce MA, Brown RO, Lowrey TS, Pritchard FE, Dickerson RN, Fabian TC. A randomized trial of isonitrogenous enteral diets after severe trauma. An immune-enhancing diet reduces septic complications. Ann Surg 1996; 224(4): 531-543.
104. Schilling J, Vranjes N, Fierz W, Joller H, Gyurech D, Ludwig E, Marathias K, Geroulanos S. Clinical outcome and immunology of postoperative arginine, omega-3 fatty acids, and nucleotide-enriched enteral feeding: a randomized prospective comparison with standard enteral and low calorie/low fat i.v. solutions. Nutrition 1996; 12(6):423-9
105. Saffle JR, Wiebke G, Jennings K, Morris SE, Barton RG. Randomized trial of immune-enhancing enteral nutrition in burn patients. J Trauma 1997; 42(5): 793-802.
106. Mendez C, Jurkovich GJ, Garcia I, Davis D, Parker A, Maier RV. Effects of an immune-enhancing diet in critically injured patients. J Trauma 1997; 42(5): 933-942.
107. Senkal M, Mumme A, Eickhoff U, Geier B, Spath G, Wulfert D, Joosten U, Frei A, Kemen M. Early postoperative enteral immunonutrition: clinical outcome and cost-comparison analysis in surgical patients. Crit Care Med 1997; 25(9): 1489-96
108. Braga M, Gianotti L, Vignali A, Cestari A, Bisagni P, Di Carlo V. Artificial nutrition after major abdominal surgery: Impact of route of administration and compostion of the diet. Crit Care Med 1998; 26(1): 24-30
109. Heys SD, Walker LG, Smith I, Eremin O, Enteral nutritional supplementation with key nutrients in patients with critical illness and cancer: a meta-analysis of randomized controlled clinical trials. Ann Surg 1999; 229(4): 467-77
110. Braga M, Gianotti L, Radaelli G, Vignali A, Mari G, Gentilini O, Di Carlo V. Perioperative immunonutrition in patients undergoing cancer surgery. Arch Surg 1999; 134(4): 428-33